Financial Year |
March 31 2023 |
Monetary Funds |
172,919,486.89 |
Held-for-trading Financial Assets |
425,793,209.41 |
Notes Receivable |
-- |
Accounts Receivable |
7,196,210.18 |
Advances to Suppliers |
28,601.80 |
Other Receivables |
137,812,251.83 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
2,963,398.12 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
15,611,845.21 |
Total Current Assets |
764,133,058.44 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
75,493.67 |
Investment Properties |
697,234,807.82 |
Fixed Assetes |
51,801,426.80 |
Under-construction Projects |
14,361,292.54 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
51,822,944.51 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
7,173,674.77 |
Deferred Income Tax Assets |
30,869,409.28 |
Other Non-Current Assets |
106,056.63 |
Sub-Total of Non-Current Assets |
968,145,827.10 |
Total Assets |
1,732,278,885.54 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
8,768,232.38 |
Accounts Received In Advance |
3,524,888.68 |
Employee Compensation Payable |
745,238.04 |
Taxes Payable |
8,164,933.34 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
11,880,780.75 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
-- |
Other Current Liabilities |
5,487,260.08 |
Sub-Total of Current Liabilities |
38,603,542.65 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
211,557.55 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
211,557.55 |
Total Liabilities |
38,815,100.20 |
Paid-In Capital(Or Share Stock) |
761,191,294.00 |
Capital Surplus |
31,113,833.00 |
Surplus Reserve |
91,146,189.72 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
809,931,257.72 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,693,463,785.34 |
Owner's Equity(Stockholder's Equity) |
1,693,463,785.34 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,732,278,885.54 |